Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
BPC-157 is also the stronger choice for research involving drug-induced damage or neuroprotection
Who BPC-157 is, and isn't, for A reasonable case for considering BPC-157 looks like this
Key Takeaways AOD 9604 produces 2-3 times greater fat loss than placebo in clinical trials with women Standard dosing ranges from 0.5mg to 1mg daily via subcutaneous injection Side effects occur in fewer than 5% of women, primarily mild injection site reactions Results typically become visible after 4-6 weeks of consistent daily administration The peptide preserves lean muscle mass while specifically targeting fat tissue How AOD 9604 Works for Female Fat Loss AOD 9604 functions by activating beta-3 adrenergic receptors in adipose tissue, specifically triggering lipolysis without the growth-promoting effects of full-length growth hormone
For diluent-specific rules, see does bacteriostatic water need to be refrigerated
US$ 26.77
US$ 22.72
US$ 23.11
US$ 21.12
